Bard PowerPort Migration Lawsuit

The Bard port catheter device is used to deliver medication, fluids, and chemotherapy directly into the bloodstream, commonly used in cancer patients and others who require long-term vascular access.

Complications have been reported after implantation, when the catheter does not remain stable or intact inside the body.

Patients have reported catheter migration, catheter fracture, and other forms of device failure that can interfere with treatment and require additional medical care.

The device’s design flaws are alleged to lead to serious health risks including vascular and cardiac damage, infections, and severe chronic pain.

Patients may face life-threatening complications requiring emergency interventions such as surgery to remove fragments or replace defective PowerPort devices due to catheter failure.

These problems are often tied to how the catheter is constructed.

The Bard PowerPort catheter is made from a polyurethane-based material called ChronoFlex, which includes barium sulfate so the device can be seen on imaging.

ChronoFlex is a mix of polyurethane and barium sulfate used in the catheter design to enhance visibility on X-rays.

That visibility can come at a tradeoff when the material does not maintain consistent strength over time.

As the material weakens, the catheter can develop small cracks and become brittle.

The Bard PowerPort lawsuits claim that the device’s material, Chronoflex AL, is defective and leads to complications such as fractures and infections. Once that breakdown begins, the risk shifts from wear to structural failure.

That failure can result in the catheter breaking apart or moving out of position within the vascular system, increasing the risk of internal injury.

The lawsuits allege that failure can cause life-threatening consequences including catheter fracture and migration, embolism, thrombosis, infections, and organ perforation.

Reported Bard PowerPort complications include conditions affecting how the catheter functions inside the body, including how it holds position, maintains structure, and functions within the bloodstream, including conditions such as:

• Catheter fracture
• Catheter migration
• Catheter infection
• Blood clots
• Damage to blood vessels

In many cases, they require medical intervention and form part of the broader bard powerport litigation involving alleged device failure.

If you or a loved one has experienced serious complications linked to a defective Bard PowerPort device, you may be eligible to pursue a Bard PowerPort lawsuit based on the injuries involved.

You can contact TorHoerman Law for a free consultation to review your case.

You can also use the chatbot on this page to check if you may be eligible to file a bard powerport lawsuit.

The Bard PowerPort is an implantable port system placed under the skin to provide repeated access to the bloodstream during ongoing treatment.

It is commonly used when a patient needs long-term intravenous therapy, including chemotherapy, infusions, or repeated blood access.

The device generally consists of two main parts: a small port reservoir placed beneath the skin and a catheter that connects the port to a large vein.

During use, a needle is inserted through the skin into the port so medication, fluids, or blood products can move through the catheter and into the bloodstream.

Bard, now part of Becton, Dickinson and Company (BD), markets PowerPort devices as implantable vascular access devices.

In reported lawsuits, plaintiffs have raised concerns about catheter fracture, migration, thrombosis, infection, and other complications allegedly linked to the device after implantation.

Who Typically Requires a Bard PowerPort Device?

The Bard PowerPort device is used in patients who require repeated access to the bloodstream over a longer period of treatment.

It is selected when short-term IV access is not sufficient and when consistent entry into the vascular system is needed for ongoing care.

Long-term therapies often involve repeated dosing, monitoring, or continuous infusion.

In these situations, the device is placed to maintain reliable access while reducing repeated needle use as part of structured patient care.

Use of the device is most commonly associated with:

• Cancer patients receiving chemotherapy: The implant port system implanted under the skin allows repeated delivery of medication during multiple treatment cycles without repeated peripheral access.
• Patients undergoing long-term infusion therapy: Individuals receiving antibiotics, nutrition, or pain management rely on a port system to maintain stable access over extended treatment periods.
• Patients requiring frequent blood sampling: The device supports repeated blood draws through the same access point, which is often necessary for ongoing monitoring.
• Patients with limited or difficult vein access: In these cases, standard IV placement may not be reliable, making correct positioning and proper placement of the catheter important for function.

The device remains in place for extended use, and its function depends on how the catheter stays positioned within the vein and how it performs during repeated access over time.

Bard PowerPort migration allegations generally involve claims that the catheter moved out of its intended position after implantation.

In a properly functioning implanted port, the catheter is supposed to remain stable within the vein during repeated use for infusions or blood access.

Plaintiffs in the Bard MDL and related lawsuits allege that material failure, catheter fracture, or structural weakness can contribute to movement, embolization, or loss of position over time.

The JPML transfer orders describe allegations that Bard’s catheter design used a barium sulfate concentration high enough to reduce material integrity and contribute to fracture, migration, thrombosis, and other complications.

Migration may be associated with several factors, including:

• Catheter fracture or material breakdown that allows part of the device to shift or separate
• Device design issues that allegedly reduce long-term structural integrity
• Implantation variables that affect how securely the catheter is placed at the outset
• Repeated flushing, infusion use, or other routine stresses placed on the device over time
• Patient movement or internal pressure changes that may affect a weakened catheter after implantation

FDA adverse-event reports also reflect migration-related complaints involving Bard PowerPort devices, including reports coded for migration, obstruction, suction problems, pain, fracture, and material separation.

Those reports do not prove causation in any individual case, but they do show that migration has been reported as a serious injuries issue in real-world use.

BD disputes the plaintiffs’ defect allegations and states that PowerPort devices are FDA-cleared and that the complications alleged in litigation are known risks identified in the instructions for use.

Serious Medical Complications From Catheter Migration

Catheter migration can lead to complications that affect how the Bard PowerPort catheter device functions inside the body.

When the device shifts from its intended position, it may interfere with surrounding structures and disrupt normal function within the vascular system.

The severity of these complications depends on where the catheter tip moves and whether the device continues to be used after displacement.

In some cases, this can result in conditions that require immediate medical intervention.

When the catheter is no longer in its intended position, a migrated catheter may affect surrounding tissue, blood vessels, and nearby structures.

These complications commonly include:

• Pain and discomfort: Movement of the catheter may irritate surrounding tissue, leading to persistent pain or swelling
• Nerve damage: A displaced catheter may affect nearby nerves, causing long-term discomfort or reduced mobility
• Blood clots and thrombosis: Disruption in blood flow may increase the risk of clot formation within blood vessels.
• Severe infections: Migration may increase infection risk, especially when the integrity of the device or surrounding tissue is affected.
• Organ perforation: In some cases, the catheter may damage nearby structures, requiring surgical intervention

Patients have reported that the Bard PowerPort device can lead to life-threatening complications requiring emergency medical interventions.

The Bard PowerPort allegedly has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position.

Bard has received numerous adverse event reports indicating that the PowerPort has a higher failure rate than other similar products on the market.

Lawsuits allege that Bard failed to adequately warn patients and healthcare providers about the risks associated with the PowerPort device.

Bard PowerPort lawsuits focus on whether the Bard PowerPort device performed as expected after implantation and whether reported failures caused injury.

Bard PowerPort lawsuits allege that the device may not maintain its condition or position over time, raising concerns about problems with Bard Power Port devices after implantation.

Migration is one of the issues raised, along with other failures reported across Bard PowerPort cases.

The claims generally focus on the following issues:

• Defective product design: The device is claimed to carry a higher risk of internal failure, including fracture and movement inside the body.
• Failure to adequately warn patients: It is alleged that risks such as catheter degradation and migration were not clearly disclosed.
• Negligence: Claims include failures in design, testing, and safety review.
• Misrepresentation of safety through regulatory clearance: Plaintiffs argue that FDA clearance was used to support safety claims despite limits of that process.

These claims are centralized in the Bard PowerPort multidistrict litigation in the U.S. District Court for Arizona.

The Bard PowerPort MDL was established in August 2023 to consolidate lawsuits alleging design defects in the Bard PowerPort devices.

The judicial panel ordered consolidation to manage similar claims and organize pretrial proceedings.

The federal cases are presided over by Judge David G. Campbell in the U.S. District Court for the District of Arizona.

Selected cases move forward as a bellwether trial to test how claims may be decided.

Bellwether trials are critical in the Bard PowerPort litigation as they help both sides assess how juries may respond to the evidence presented.

The outcomes of the Bard PowerPort bellwether trials may influence settlement negotiations for the remaining cases in the Bard PowerPort MDL.

Bard Port Catheter Lawsuit Settlement Estimates and Projections

There is no confirmed global settlement in the bard port catheter lawsuit at this stage.

Any discussion of PowerPort lawsuit settlement amounts reflects projected ranges based on reported injuries and how claims are being evaluated in ongoing litigation.

Estimates for Bard Power Port Lawsuit Settlement Amounts are as follows:

• Cases involving vascular damage directly resulting from at least one occurrence event could have a settlement payout value ranging from $175,000 to $350,000.
• Cases of thrombosis or pulmonary embolism may have a settlement value of around $100,000 to $250,000.
• Infection cases related to Bard PowerPort devices will likely have a settlement value range of $30,000 to $100,000.

The average settlement payout for Bard PowerPort lawsuits is projected to be between $150,000 to $300,000, with some claims potentially exceeding $1 million.

These projections vary depending on injury severity, treatment, and overall impact of the Bard PowerPort injuries reported in each case.

Bellwether trials can establish benchmarks for liability and damages, which often drives broader settlement discussions.

At TorHoerman Law, our team of experienced Bard PowerPort lawyers can help you through the legal process in an attempt to obtain the compensation you deserve.

We understand the physical, emotional, and financial toll that medical device problems can have on patients and their families, which is why we are dedicated to providing compassionate and effective representation to our clients.

We can help you recover damages for medical expenses, lost wages, pain and suffering, and other losses related to your Bard PowerPort complications.

If you or a loved one has experienced health complications related to the Bard PowerPort device, you may be eligible to file a Bard PowerPort Lawsuit.

Contact TorHoerman Law today for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Bard PowerPort lawsuit instantly.

Our legal team is here to help you through the legal process.

Reach out to us with any questions you may have about the Bard PowerPort Lawsuit, defects on Bard PowerPort catheters, and more.